Chronic Pain Features Relate to Quality of Life More than Physiopathology: A Cross‐Sectional Evaluation in Pain Clinics

Pérez, Concepción; Margarit, César; Sánchez-Magro, Isabel; Antonio, Ana de; Villoria, Jesús

doi:10.1111/papr.12533

Cited by 25 publications

(23 citation statements)

References 53 publications

(81 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As in this study, CWP adds to the burden of the disease with a lower self-reported HRQoL. 13 Interestingly, also patients with CWP improved in the invasively treated group but not in the noninvasively treated group, indicating that the presence of CWP not should be a cause to withhold invasive treatment.…”

Section: Discussionsupporting

confidence: 46%

Patients With Intermittent Claudication and Chronic Widespread Pain Improves in Health-Related Quality of Life After Invasive but Not After Noninvasive Treatment

Lindgren

Pärsson

Gottsäter

et al. 2017

Clin Med Insights Cardiol

View full text Add to dashboard Cite

Background:Intermittent claudication (IC) is traditionally managed with risk factor modification, best medical treatment (BMT), and exercise training. Comorbidities such as diabetes and ischemic heart disease affect both results of invasive treatment and health-related quality of life (HRQoL) negatively. It is unknown how chronic widespread pain (CWP) influences the results of invasive treatment. We evaluated the influence of CWP on HRQoL in patients undergoing invasive (open surgery or endovascular treatment) and noninvasive BMT of IC.Methods:A total of 242 patients with IC treated with invasive or noninvasive methods responded to the validated HRQoL questionnaires Short Form 36 Health Survey, EuroQoL 5-dimensions, and distribution of pain with the Epipain questionnaire at baseline and after 12 months.Results:Invasively treated patients without CWP improved in all primary outcome measures. Patients with CWP reported significant improvements in most of the HRQoL-related outcome measures after invasive treatment, but patients with CWP in the noninvasive treatment group did not improve in any HRQoL-related outcome measure.Conclusions:The presence of CWP not should be a cause to withhold invasive treatment in patients with IC.

show abstract

Section: Discussionsupporting

confidence: 46%

Patients With Intermittent Claudication and Chronic Widespread Pain Improves in Health-Related Quality of Life After Invasive but Not After Noninvasive Treatment

Lindgren

Pärsson

Gottsäter

et al. 2017

Clin Med Insights Cardiol

View full text Add to dashboard Cite

show abstract

“…Regarding QoL, some research has reported low levels of this outcome measure in patients with NP compared with both the general population 36 and patients suffering from other chronic conditions. 3 Recently, Pérez et al 33 reported that the QoL of patients with NP was significantly impaired, although this study presented no information regarding comparison of HRQL between patients with CNP and PNP. In our study, the QoL of the CNP patients was more affected than that of the PNP patients.…”

Section: Discussionmentioning

confidence: 79%

“…Some authors, such as Schaefer et al, 13 have found that over 50% of the subjects with NP in the US have some level of anxiety (61.9%) and depression (54.4%), with similar results seen across each of the NP conditions, with more severe pain related to a higher score on scales of anxiety and depression. Pérez et al 33 have also shown this association in patients with nociceptive, neuropathic or mixed pain, and de Andrés et al 34 have reported that over half of the patients with uncontrolled NP were diagnosed with depression and 43% with anxiety. However, neither of these authors analyzed the frequency and association of these processes in patients with CNP and PNP studied separately.…”

Section: Discussionmentioning

confidence: 91%

See 1 more Smart Citation

Prevalence of central and peripheral neuropathic pain in patients attending pain clinics in Spain: factors related to intensity of pain and quality of life

Failde¹,

Dueñas²,

Ribera³

et al. 2018

JPR

Self Cite

View full text Add to dashboard Cite

BackgroundThe objective of the study was to estimate the prevalence of pure central neuropathic pain (CNP) and peripheral neuropathic pain (PNP) among patients attending pain clinics in Spain. The study also aimed to analyze factors associated with pain intensity and quality of life (QoL).MethodsA cross-sectional study was performed including 53 patients with pure CNP and 281 with pure PNP attending in 104 pain clinics in Spain. The revised grading system proposed in 2008 to determine a definite, probable or possible diagnosis of NP was used. Pain features, psychological variables and QoL were assessed. Descriptive, bivariate and multivariate analyses were performed.ResultsThe prevalence of pure CNP and PNP amongst neuropathic pain patients was 2.4% (95% CI: 1.7;3.1) and 12.9% (95% CI: 1.5;14.3), respectively. Comorbid anxiety, depression or sleep disorders were high in both groups, but higher in CNP patients (51.1%, 71.4%, respectively). Pain intensity in PNP patients was associated with the presence of depression and sleep disturbances. However, in CNP patients, it was related with pain in the lower limbs. The impairment of QoL was greater in CNP patients than in PNP patients; pain location, presence of depression and sleep disturbance were the factors that most negatively affected QoL. Among PNP patients, women and those with higher pain intensity had worse QoL.ConclusionPain intensity and QoL are affected by different factors in patients suffering from CNP or PNP. Identifying these factors could serve to guide therapeutic strategies and improve the QoL of patients.

show abstract

“…Concepción Pérez Hernández concha.phte@gmail.com El dolor neuropático tiene una prevalencia entre el 4 y el 8 % de la población, según diversos estudios. Clínicamente la intensidad del dolor es 2 puntos superior al dolor nociceptivo, con mayor repercusión sobre la calidad de vida, la ansiedad, el sueño y la depresión (1). Hasta un 37 % de los procesos de lumbalgia crónica se asocian a radiculopatía, la causa más frecuente de dolor neuropático (2), siendo la causa más frecuente de dolor neuropático en las unidades de dolor en España (3).…”

Section: Correspondenciaunclassified

Metamizol como inmunomodulador en el dolor neuropático

Hernández

2020

Rev. Soc. Esp. Dolor.

View full text Add to dashboard Cite

Este es un archivo PDF de un manuscrito inédito que ha sido aceptado para su publicación en la Revista de la Sociedad Española del Dolor. Como un servicio a nuestros clientes estamos proporcionando esta primera versión del manuscrito en estado de prepublicación. El manuscrito será sometido a la corrección de estilo final, composición y revisión de la prueba resultante antes de que se publique en su forma final. Tenga en cuenta que durante el proceso de producción se pueden dar errores lo que podría afectar el contenido final. El copyright y todos los derechos legales que se aplican al artículo pertenecen a la

show abstract

Chronic Pain Features Relate to Quality of Life More than Physiopathology: A Cross‐Sectional Evaluation in Pain Clinics

Cited by 25 publications

References 53 publications

Patients With Intermittent Claudication and Chronic Widespread Pain Improves in Health-Related Quality of Life After Invasive but Not After Noninvasive Treatment

Patients With Intermittent Claudication and Chronic Widespread Pain Improves in Health-Related Quality of Life After Invasive but Not After Noninvasive Treatment

Prevalence of central and peripheral neuropathic pain in patients attending pain clinics in Spain: factors related to intensity of pain and quality of life

Metamizol como inmunomodulador en el dolor neuropático

Contact Info

Product

Resources

About